Quantitative analysis of tryptase- and chymase-containing mast cells in atopic dermatitis and nummular eczema

British Journal of Dermatology

Volumn 136, Issue 6, 1997, Pages 871-877

  Jarvikallio A ^a   Naukkarinen, A ^a   Harvima, I T ^a   Aalto, M L ^a   Horsmanheimo, M ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CHYMASE; PROTEINASE; TRYPTASE;

ADOLESCENT; ADULT; AGED; ALLERGIC REACTION; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DERMIS; ECZEMA; FEMALE; HUMAN; HUMAN TISSUE; MALE; MAST CELL; PRIORITY JOURNAL; SKIN DEFECT; SKIN INFLAMMATION;

EID: 0030844701     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb03927.x     Document Type: Article

References (36)

1. Irani AA, Schechter NM, Craig SS et al. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 1986; 83: 4464-8.
2. TC types of human mast cells by immunohistochemistry using new monoclonal antitryptase and anti-chymase antibodies. J Histochem Cytochem 1989; 37: 1509-15.
3. TC cells. J Immunol 1991; 247-53.
4. TC type of human mast cells. J Immunol 1990; 145: 2652-61.
5. Weidner N, Austen KF. Heterogeneity of mast cells at multiple body sites: Fluorescent determination of avidin binding and immunofluorescent determination of chymase, tryptase, and carboxypeptidase content. Pathol Res Pract; 1993; 189: 156-62.
6. Irani AA, Sampson HA, Schwartz LB. Mast cells in atopic dermatitis. Allergy 1989; 44 (Suppl.) (9): 31-4.
7. Craig SS, Schechter NM, Schwartz LB. Ultrastructural analysis of human T and TC mast cells identified by immunoelectron microscopy. Lab Invest 1988; 58: 682-91.
8. Church MK, Lowman MA, Robinson C et al. Interaction of neuropeptides with human mast cells. Int Arch Allergy Appl Immunol 1989; 88: 70-8.
9. Church MK, El-Lati S, Okayama Y. Biological properties of human skin mast cells. Clin Exp Allergy 1991; 21: 1-9.
10. Kubota Y. The effect of human anaphylatoxins and neutrophils on histamine release from isolated human skin mast cells. J Dermatol 1992; 19: 19-26.
11. van Overveld FJ, Jorens PhG, Rampart M et al. Tumor necrosis factor stimulates human skin mast cells to release histamine and tryptase. Clin Exp Allergy 1991; 21: 711-14.
12. Subramanian N, Bray MA. Interleukin-1 releases histamine from human basophils and mast cells in vitro. J Immunol 1987; 138: 271-5.
13. Horsmanheimo L, Harvima IT, Järvikallio A et al. Mast cells are one major source of interleukin-4 in atopic dermatitis. Br J Dermatol 1994; 131: 348-53.
14. Horsmanheimo L, Harvima IT, Harvima RJ et al. Interferon-gamma in mast cells of psoriatic skin. Allergologie 1994; 17: 225.
15. Montgomery Smith J. Epidemiology and natural history of asthma, allergic rhinitis and atopic dermatitis (eczema). In: Allergy. Principles and Practice (Middleton E, Reed CE et al.) St Louis: Mosby, 1988; 891-929.
16. Mihm MC, Soter NA, Dvorak HF, Austen KF. The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 1976; 67: 305-12.
17. Sugiura H, Hirota Y, Uehara M. Heterogenous distribution of mast cells in lichenified lesions of atopic dermatits. Acta Derm Venereol (Stockh) Suppl. 1989; 144: 115-18.
18. Harvima IT, Horsmanheimo L, Naukkarinen A, Horsmanheimo M. Mast Cell proteinases and cytokines in skin inflammation. Arch Dermatol Res. 1994; 287 (1): 61-7.
19. Harvima IT, Naukkarinen A, Harvima RJ, Fräki J. Immunoperoxidase and enzyme-histochemical demonstration of human skin tryptase in cutaneous mast cells in normal and mastocytoma skin. Arch Dermatol Res 1988; 280: 363-70.
20. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980; 92 (Suppl.): 44-7.
21. Burton JL. Eczema lichenification prurigo and erythroderma. In: Textbook of Dermatology (Rook A, Wilkinson D, Ebling FJ, eds). Oxford: Blackwell Scientific Publications. 1992; 1: 555-7.
22. Harvima IT, Naukkarinen A, Harvima RJ, Horsmanheimo M. Enzyme- and immunohistochemical localization of mast cell tryptase in psoriatic skin. Arch Dermatol Res 1989; 281: 387-91.
23. Harvima IT, Naukkarinen A, Harvima RJ et al. Quantitative enzyme-histochemical analysis of tryptase- and chymase-containing mast cells in psoriatic skin. Arch Dermatol Res 1990; 282: 428-33.
24. Alter SC, Kramps JA, Janoff A, Schwartz LB. Interactions of human mast cell tryptase with biological protease inhibitors. Arch Biochem Biophys 1990; 276: 26-31.
25. Töyry S, Fräki JE, Tammi R. Mast cell density in psoriatic skin. The effect of PUVA and corticosteroid therapy. Arch Dermatol Res 1988; 280: 282-5.
26. Harvima IT, Harvima RJ, Naukkarinen A, Horsmanheimo M. Skin tryptase: features and expression in human dermatological disorders. In: Mast Cell Proteases in Immunology and Bioloyy (Caughey GH, ed.). New York: Marcel Dekker, 1995: 25-46.
27. Harvima IT, Schwartz LB. Mast cell products in the monitoring of allergic inflammation. In: Progress in Allergy and Clinical Immunology (Miyamoto T, Okuda M, eds). Seattle: Hogrefe and Huber, 1992; 2: 184-90.
28. Schlechter NM, Sprows JL, Schoenberger OL et al. Reaction of human skin chymotrypsin-like proteinase chymase with plasma proteinase inhibitors. J Biol Chem 1989; 264: 21308-15.
29. Caughey GH, Leidig F, Viro NF, Nadel JA. Substance P and vasoactive intestinal polypeptide degradation by mast cell tryptase and chymase. J Pharmacol Exp Ther 1988; 244: 133-7.
30. Tunon de Lara JM, Okayama Y, McEuen AR et al. Release and inactivation of interleukin-4 by mast cells. Ann NY Acad Sci 1994; 725: 50-8.
31. Mizutani H, Schechter N, Lazarus G et al. Rapid and specific conversion of precursors interleukin 1β (IL-1β) to an active IL-1 species by human mast cell chymase. J Exp Med 1991; 174: 821-5.
32. Harvima IT, Naukkarinen A, Paukkonen K et al. Mast cell tryptase and chymase in developing and mature psoriatic lesions. Arch Dermatol Res 1993; 285: 184-92.
33. van der Heijden FL, Wierenga EA, Bos JD, Kapsenberg ML. High frequency of IL-4-producing CD4+ allergen-specific T lymphocytes in atopic dermatitis. J Invest Dermatol 1991; 97: 389-94.
34. Kalayama I, Yokozeki H, Nishioka K. Mast-cell-derived mediators induce epidermal cell proliferation: clue for lichenified skin lesion formation in atopic dermatitis. Int Arch Allergy Immunol 1992; 98: 410-14.
35. Adams JC, Watt FM. Fibronectin inhibits the terminal differentiation of human keratinocytes. Nature 1989; 340: 307-9.
36. Lohi J, Harvima I, Keski-Oja J. Pericellular substrates of human mast cell tryptase: 72 000 dalton gelatinase and fibronectin. J Cell Biochem 1992; 50: 337-49.